grant

Development of a minimally invasive optical biosensor to improve hyperphosphatemia management

Organization TEXAS ENGINEERING EXPERIMENT STATIONLocation COLLEGE STATION, UNITED STATESPosted 1 Sept 2023Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY20231,2-Ethanediol2-HydroxyethanolAddressAnimal ModelAnimal Models and Related StudiesAutoregulationBiocompatible MaterialsBiomaterialsBiomedical EngineeringBiosensing TechnicsBiosensing TechniquesBiosensorBloodBlood Reticuloendothelial SystemBlood SerumCalciumCalibrationCardiovascularCardiovascular Body SystemCardiovascular Organ SystemCardiovascular systemCell Communication and SignalingCell SignalingChildhoodChronic Kidney FailureChronic Renal DiseaseChronic Renal FailureClinicalData SetDetectionDevelopmentDiagnostic testsDiffusionDihydroxyethanesDiseaseDisease modelDisorderDrugsESRDEncapsulatedEnd stage renal failureEnd-Stage Kidney DiseaseEnd-Stage Renal DiseaseEngineeringEthanediolsEthylene GlycolsExhibitsFoundationsGoalsHeart VascularHistologicHistologicallyHomeHomeostasisHydrogelsImmune responseImmune systemImmunological responseImplantIn VitroIngestionIntakeIntercellular FluidIntermediary MetabolismInterstitial FluidsInterventionIntervention StrategiesIntracellular Communication and SignalingKO miceKidney DiseasesKnock-out MiceKnockout MiceMeasurementMeasuresMedicationMedicineMetabolic ProcessesMetabolismMetalloporphyrinsMonitorMonoethylene GlycolMorbidityMorbidity - disease rateNephropathyNon-Invasive DetectionNoninvasive DetectionNull MouseO elementO2 elementOptical MethodsOpticsOxygenPatientsPerformancePharmaceutic PreparationsPharmaceutical PreparationsPhosphatesPhosphorousPhosphorusPhysiciansPhysiologicPhysiologicalPhysiological HomeostasisPopulationPorosityPorphyrinsPyruvatePyruvate OxidaseRenal DiseaseResearchScientistSerumSignal TransductionSignal Transduction SystemsSignalingSkinTechnologyTestingTexasThickThicknessTitrationsUniversitiesabsorptionacetyl phosphateassociate facultyassociate professorbio-engineeredbio-engineersbiocompatibilitybioengineeringbiological engineeringbiological materialbiological sensorbiological signal transductionbiomaterial compatibilitybiosensingchronic kidney diseasecirculatory systemclinical translationclinically translatablecollegecollegiatecrosslinkdensitydesigndesigningdevelopmentaldiet restrictiondietarydietary restrictiondiffuseddiffusesdiffusingdiffusionsdisorder modeldrug/agentempowermentethylene glycolhomeshost responseimmune system responseimmunoresponseimplant materialimprovedimproved outcomein vitro testingin vivoin vivo evaluationin vivo testingingestinorganic phosphateinterventional strategykidney disordermid-career facultymidcareer facultyminimally invasivemodel of animalmortalitymouse modelmurine modelnew technologynon-invasive monitornoninvasive monitornovel technologiesopticalparticlepediatricphosphorescenceprofessorrenal disorderrestricted dietsensorstandard of caretool
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Calcium and phosphate homeostasis is significantly disrupted in advanced chronic kidney disease

(CKD) and end-stage kidney disease. Elevated serum phosphate concentration – a condition known

as hyperphosphatemia – is a significant cause of cardiovascular morbidity and mortality in this

population. Thus, physicians treat these patients with dietary restriction of phosphorus intake and

medications that inhibit the absorption of ingested phosphorus. The standard of care is to titrate these

interventions to a patient’s serum phosphate concentration, but this level is checked only at monthly

intervals, which provides only an infrequent snapshot of a patient’s dynamic condition. Thus, new

technology for phosphate monitoring is needed to empower physicians and patients to better manage

hyperphosphatemia. The objective of this project is to address this need through the development of

an optical biosensor that can be used to non-invasively measure serum phosphate concentration.

Aim 1 is focused on biosensor development, which will be approached by designing hydrogel

composites encapsulating metalloporphyrin-containing biosensor particles that will transduce

phosphate concentration to an optical signal that can be detected through the skin. In vitro testing

under simulated physiologic conditions will be performed to optimize the range and sensitivity of the

biosensor. Aim 2 encompasses in vivo testing of the biosensor. Testing will be performed in the

Col4a3 knockout mouse model of CKD, which exhibits dysregulated calcium and phosphate

metabolism and hyperphosphatemia. Biosensor performance will be evaluated by comparison to

blood and interstitial fluid measurements of phosphate. If successful, this project will provide a

foundation for subsequent testing in a large animal model of CKD and efforts toward clinical

translation.

Grant Number: 1R21DK134921-01A1
NIH Institute/Center: NIH

Principal Investigator: Daniel Alge

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →